These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27538899)

  • 1. Ganglionic acetylcholine receptor autoantibodies in patients with autoimmune diseases including primary biliary cirrhosis.
    Maeda Y; Nakane S; Higuchi O; Nakamura H; Komori A; Migita K; Mukaino A; Umeda M; Ichinose K; Tamai M; Kawashiri SY; Sakai W; Yatsuhashi H; Kawakami A; Matsuo H
    Mod Rheumatol; 2017 Jul; 27(4):664-668. PubMed ID: 27538899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barré syndrome.
    Nakane S; Higuchi O; Hamada Y; Maeda Y; Mukaino A; Sakai W; Kusunoki S; Matsuo H
    J Neuroimmunol; 2016 Jun; 295-296():54-9. PubMed ID: 27235349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome.
    Mukaino A; Nakane S; Higuchi O; Nakamura H; Miyagi T; Shiroma K; Tokashiki T; Fuseya Y; Ochi K; Umeda M; Nakazato T; Akioka S; Maruoka H; Hayashi M; Igarashi S; Yokoi K; Maeda Y; Sakai W; Matsuo H; Kawakami A
    Mod Rheumatol; 2016 Sep; 26(5):708-15. PubMed ID: 26873295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglionic Acetylcholine Receptor Antibodies and Autonomic Dysfunction in Autoimmune Rheumatic Diseases.
    Imamura M; Mukaino A; Takamatsu K; Tsuboi H; Higuchi O; Nakamura H; Abe S; Ando Y; Matsuo H; Nakamura T; Sumida T; Kawakami A; Nakane S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
    Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to the α3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis.
    Yamakawa M; Mukaino A; Kimura A; Nagasako Y; Kitazaki Y; Maeda Y; Higuchi O; Takamatsu K; Watari M; Yoshikura N; Ikawa M; Sugimoto I; Sakurai Y; Matsuo H; Ando Y; Shimohata T; Nakane S
    J Neuroimmunol; 2020 Dec; 349():577399. PubMed ID: 32980672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies.
    Nakane S; Umeda M; Kawashiri SY; Mukaino A; Ichinose K; Higuchi O; Maeda Y; Nakamura H; Matsuo H; Kawakami A
    Arthritis Res Ther; 2020 Feb; 22(1):32. PubMed ID: 32085768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ganglionic AChR antibodies in Japanese patients with motility disorders.
    Mukaino A; Minami H; Isomoto H; Hamamoto H; Ihara E; Maeda Y; Higuchi O; Okanishi T; Kokudo Y; Deguchi K; Sasaki F; Ueki T; Murata KY; Yoshida T; Kinjo M; Ogawa Y; Ido A; Matsuo H; Nakao K; Nakane S
    J Gastroenterol; 2018 Dec; 53(12):1227-1240. PubMed ID: 29766276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy.
    Nakane S; Mukaino A; Higuchi O; Yasuhiro M; Takamatsu K; Yamakawa M; Watari M; Tawara N; Nakahara KI; Kawakami A; Matsuo H; Ando Y
    J Autoimmun; 2020 Mar; 108():102403. PubMed ID: 31924415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients.
    Nakane S; Higuchi O; Koga M; Kanda T; Murata K; Suzuki T; Kurono H; Kunimoto M; Kaida K; Mukaino A; Sakai W; Maeda Y; Matsuo H
    PLoS One; 2015; 10(3):e0118312. PubMed ID: 25790156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis.
    Mayo I; Arizti P; Parés A; Oliva J; Doforno RA; de Sagarra MR; Rodés J; Castaño JG
    J Hepatol; 2000 Oct; 33(4):528-36. PubMed ID: 11059856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease.
    Briani C; Doria A; Ruggero S; Toffanin E; Luca M; Albergoni MP; D'Odorico A; Grassivaro F; Lucchetta M; De Lazzari F; Balzani I; Battistin L; Vernino S
    Autoimmunity; 2008 Feb; 41(1):100-4. PubMed ID: 18176871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of autoimmune diseases and clinical significance of autoantibody profile: Data from National Institute of Hygiene in Rabat, Morocco.
    Missoum H; Alami M; Bachir F; Arji N; Bouyahya A; Rhajaoui M; El Aouad R; Bakri Y
    Hum Immunol; 2019 Jul; 80(7):523-532. PubMed ID: 30807792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-actin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA.
    Leibovitch L; George J; Levi Y; Bakimer R; Shoenfeld Y
    Immunol Lett; 1995 Dec; 48(2):129-32. PubMed ID: 8719111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of anti-acetylcholine receptor antibody activity in patients with anti-mitochondrial antibodies.
    Sundewall AC; Lefvert AK; Norberg R
    Clin Immunol Immunopathol; 1987 Nov; 45(2):184-95. PubMed ID: 3665199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosis.
    Roesler KW; Schmider W; Kist M; Batsford S; Schiltz E; Oelke M; Tuczek A; Dettenborn T; Behringer D; Kreisel W
    Dig Dis Sci; 2003 Mar; 48(3):561-9. PubMed ID: 12757171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases.
    Utiyama SR; Zenatti KB; Nóbrega HA; Soares JZ; Skare TL; Matsubara C; Muzzilo DA; Nisihara RM
    Immunol Invest; 2016 Aug; 45(6):566-73. PubMed ID: 27409579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis.
    Santiago M; Baron M; Miyachi K; Fritzler MJ; Abu-Hakima M; Leclercq S; Bell M; Hudson M; Mathieu JP; Taillefer S; Jones N; Docherty P; Khraishi M; Markland J; Pope J; Robinson D; Smith D; Sutton E
    Clin Rheumatol; 2008 Jan; 27(1):77-83. PubMed ID: 17570008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.